home / stock / vynt / vynt news

VYNT News and Press, Vyant Bio Inc. From 05/16/22

Stock Information
Company Name: Vyant Bio Inc.
Stock Symbol: VYNT
Market: NASDAQ
Website: vyantbio.com
Menu
VYNT VYNT Quote VYNT Short VYNT News VYNT Articles VYNT Message Board
Get VYNT Alerts

News, Short Squeeze, Breakout and More Instantly...
VYNT - Vyant Bio Reports First Quarter 2022 Results and Provides Strategic and Business Highlights

Conference Call and Webcast Today at 4:30 pm ET Scientific and Business Highlights Financial Highlights CHERRY HILL, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT) is an innovative bi...
VYNT - Notable earnings after Monday's close

ADMP, ALBO, ANY, AREC, ASTS, AXDX, CCSI, OTCQX:CWBHF, CWBR, CYRN, DAC, DADA, DNA, EGLX, FTK, FUV, GAN, GLBE, GNLN, HYRE, INPX, IONQ, IPWR, ISUN, IZEA, KBNT, KULR, MARK, MVST, OTCQB:NEXCF, NU, OTCQX:PLNHF, PPSI, PYR, QIPT, REED, REKR, RGTI, RKLB, RMTI, SHLS, OTCQX:SHWZ, SLGG, SNDL, SPI, SPRO, ...

VYNT - Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022

CHERRY HILL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company’s ...

VYNT - Vyant Bio Announces Participation in BioNJ's 12th Annual BioPartnering Conference

CHERRY HILL, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders, announced that Jay Robe...
VYNT - VTNR, MF and SABS among mid-day movers

Gainers: Longeveron (LGVN) +62%. Clovis Oncology (CLVS) +61%. Icosavax (ICVX) +26%. Integrated Media Technology (IMTE) +28%. SAB Biotherapeutics (SABS) +21%. Local Bounti (LOCL) +21%. CPS Technologies (CPSH) +18%. Vector Group (VGR) +17%. Nano-X Imaging (NNOX) +16%. Vertex Energy (VTNR) +16%....

VYNT - Clovis, Longeveron top healthcare gainers; while Clarus, Acutus among losers

Gainers: Clovis Oncology CLVS +68%. Longeveron LGVN +36%. Icosavax (ICVX) +27%. Creative Medical Technology (CELZ) +25%. Nano-X Imaging NNOX +22%. Losers: Clarus Therapeutics CRXT -27%. Acutus Medical AFIB -18%. Vyant Bio VYNT -15%. Phree...

VYNT - IQ, FUTU and VYNT among pre market losers

Arcadia Biosciences (RKDA) -25% on Q4 results. UiPath (PATH) -19% on Q4 results. Clarus Therapeutics (CRXT) -18% on Q4 results. Sharecare (SHCR) -15% on Q4 results. InflaRx (IFRX) -13% vilobelimab fails to show statistical significance in seve...
VYNT - Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks are a hot subject today with several of the top companies in the market seeing major gains on Wednesday! Source: John Brueske / Shutterstock.com Before we get into all the latest penny stocks news today...

VYNT - AKBA, TMC and ISIG among mid-day movers

Gainers: Adagio Therapeutics (ADGI) +47%. Insignia Systems (ISIG) +26%. Romeo Power (RMO) +24%. Vir Biotechnology (VIR) +20%. TMC the metals company (TMC) +19%. Arhaus (ARHS) +19%. Ambac Financial Group (AMBC) +18%. Pear Therapeutics (PEAR) +17%. Vyant Bio (VYNT) +16%. Sportradar (SRAD) +16%....

VYNT - Vyant Bio, Inc. (VYNT) CEO Jay Roberts on Q4 2021 Results - Earnings Call Transcript

Vyant Bio, Inc. (VYNT) Q4 2021 Earnings Conference Call March 30, 2022 8:30 AM ET Company Participants Jay Roberts - Chief Executive Officer Andrew LaFrence - Chief Financial Officer Robert Fremeau - Chief Scientific Officer Conference Call Participants Ed White - H.C. Wainwright Presentation...
Previous 10 Next 10